医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

endpoint Expands Global Footprint to Meet Growing Client Demand

2018年06月11日 PM09:00
このエントリーをはてなブックマークに追加


 

SAN FRANCISCO

endpoint Clinical, an industry leading global interactive response technology (IRT) company, has expanded their global footprint to provide more streamlined support for their local clients in Europe and Asia. The incorporation of endpoint Clinical UK and endpoint Clinical India provides a foundation upon which endpoint can expand local development and support teams in Europe and Asia.

“At endpoint, our goal is to ensure we are continuing to provide customers with exceptional service coupled with optimal IRT solutions to manage their clinical trials with ease,” said Chuck Harris, CEO of endpoint. “By investing in providing enhanced local support, it ensures that our clients in Europe and Asia will continue to have timely responses to their queries, leading IRT experts in the region supporting their clinical trials, and a valuable partner with awareness of local regulations and trends.”

Expanding on their success in the U.S., endpoint incorporated endpoint UK and endpoint India over the past few months. The decision to invest in establishing these locations was driven by a strong customer demand. endpoint expects to aggressively expand its headcount to meet the local demand in both regions.

“Our goal is to remain a stable and responsive partner for our clients and to continue to identify strategic delivery hubs throughout the world to consistently offer stellar service and delivery on their projects,” says Christine Oliver, COO.

Read more about endpoint’s solutions at endpointclinical.com.

About endpoint

endpoint is an interactive response technology (IRT®) systems and solutions provider that supports the life sciences industry. Since 2009, we have been working with a single vision in mind, to help sponsors and pharmaceutical companies achieve clinical trial success. Our solutions, realized through the proprietary PULSE® platform, have proven to maximize the supply chain, minimize operational costs, and ensure timely and accurate patient dosing. endpoint is headquartered in San Francisco, California, with offices across the United States, Europe, and Asia.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180611005202/en/

CONTACT

endpoint
Catherine Ditzler, +1 415-688-3424
Senior
Marketing Manager
cditzler@endpointclinical.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • MetLife’s New Blockchain Health Insurance Product Eliminates Claims
  • Murata Invests in MEMS Sensor Manufacturing in Finland
  • Evaluate Ltd: Small Drug Developers Continue to Hold All the Cards, While Young Device Makers Suffer from a Shrinking Pool of Buyers
  • ABLIC Inc. Launches the S-85M0A Series of Ultra-High Efficiency Step-Down Switching Regulators in the Industry’s Most Compact(*) Size
  • Vertex Receives a Positive PBAC Recommendation for Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) to Treat Australians Ages Six and Over with Cystic Fibrosis and Two Copies of the F508del Mutation